There have been a number of articles in the press recently about drug patents and pricing. Much of the recent furor stems from the move by Turing Pharmaceuticals’ CEO Martin Shkreli to increase the price of pyremthamine, an ancient, generic antibiotic used to treat certain rare infections, 5000% from $13.50 to $750 per pill. Hilary Clinton and others have vowed to take action.